REG - General Elec. - Director/PDMR Shareholding
13/06/2023 07:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230613:nRSM4717Ca&default-theme=true
RNS Number : 4717C General Electric Company 12 June 2023
4
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION OMB APPROVAL
Washington, D.C. 20549 OMB Number: 3235-0287
Estimated average burden
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP hours per response: 0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
Check this box if no longer subject to Section 16. Form 4 or Form 5
obligations may continue. See Instruction 1(b).
Check this box if no longer subject to Section 16. Form 4 or Form 5
obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person(*) 2. Issuer Name and Ticker or Trading Symbol 5. Relationship of Reporting Person(s) to Issuer
GENERAL ELECTRIC CO GE HealthCare Technologies Inc.
(Check all applicable)
(/cgi-bin/browse-edgar?action=getcompany&CIK=0000040545) (/cgi-bin/browse-edgar?action=getcompany&CIK=0001932393) [ GEHC ]
Director X 10% Owner
Officer (give title below) Other (specify below)
(Last) (First) (Middle)
ONE FINANCIAL CENTER, SUITE 3700
(Street)
BOSTON MA 02111
(City) (State) (Zip)
3. Date of Earliest Transaction (Month/Day/Year)
06/12/2023
4. If Amendment, Date of Original Filed (Month/Day/Year) 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Ru
le
10
b5
-1
(c
)
Tr
an
sa
ct
io
n
In
di
ca
ti
on
Ch
ec
k
th
is
bo
x
to
in
di
ca
te
th
at
a
tr
an
sa
ct
io
n
wa
s
ma
de
pu
rs
ua
nt
to
a
co
nt
ra
ct
,
i
ns
tr
uc
ti
on
or
wr
it
te
n
pl
an
th
at
is
in
te
nd
ed
to
sa
ti
sf
y
th
e
af
fi
rm
at
iv
e
de
fe
ns
e
co
nd
it
io
ns
of
Ru
le
10
b5
-1
(c
).
Se
e
In
st
ru
ct
io
n
10
.
C
he
ck
th
is
bo
x
to
in
di
ca
te
th
at
a
tr
an
sa
ct
io
n
wa
s
ma
de
pu
rs
ua
nt
to
a
co
nt
ra
ct
,
in
st
ru
ct
io
n
or
wr
it
te
n
pl
an
th
at
is
in
te
nd
ed
to
sa
ti
sf
y
th
e
af
fi
rm
at
iv
e
de
fe
ns
e
co
nd
it
io
ns
of
Ru
le
10
b5
-1
(c
).
Se
e
In
st
ru
ct
io
n
10
.
(Last) (First) (Middle)
ONE FINANCIAL CENTER, SUITE 3700
(Street)
BOSTON MA 02111
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc.
(/cgi-bin/browse-edgar?action=getcompany&CIK=0001932393) [ GEHC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/12/2023
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Rule 10b5-1(c) Transaction Indication
Check this box to indicate that a transaction was made pursuant to a contract,
instruction or written plan that is intended to satisfy the affirmative
defense conditions of Rule 10b5-1(c). See Instruction 10.
Check this box to indicate that a transaction was made pursuant to a contract,
instruction or written plan that is intended to satisfy the affirmative
defense conditions of Rule 10b5-1(c). See Instruction 10.
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially
Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
(Instr. 3 and 4)
Code V Amount (A) or (D) Price
Common stock, par value $0.01 per share((1)) 06/12/2023 J((1)) 25,000,000 D ((2)) 65,331,302 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 8. Price of Derivative Security (Instr. 5) 9. Number of derivative 10. Ownership Form: Direct (D) or Indirect (I) 11. Nature of Indirect Beneficial Ownership
Security (Month/Day/Year) 4 and 5) 4) Securities Beneficially Owned (Instr. 4) (Instr. 4)
Following Reported
Transaction(s) (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The reporting person exchanged 25,000,000 shares of the common stock of the
Issuer to extinguish $1,950 million aggregate principal amount of indebtedness
under a short-term credit facility of the reporting person in a
debt-for-equity exchange.
2. The value of the Issuer's common stock for purposes of the debt-for-equity
exchange was $78.00 per share.
/s/ Brandon Smith, Vice President, Chief Corporate, Securities & Finance 06/12/2023
Counsel
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4
(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal
Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If
space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form
are not required to respond unless the form displays a currently valid OMB
Number.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHEAEKAFFLDEAARecent news on General Electric Co
See all newsREG - GE CapUK Fd Unltd Co - Annual Financial Report
AnnouncementREG - GE CapEur Fd Unld Co - Annual Financial Report
AnnouncementREG - General Elec. - 1st Quarter Results
AnnouncementREG - Allianz Global Invs - Top 10 Holdings
AnnouncementREG - General Elec. - Annual Financial Report
Announcement